By Alanna Ketler, Collective Evolution
The DEA has just announced that the same manufacturer of the notorious fentanyl has produced a synthetic marijuana product they deem more medically valuable and safer than real cannabis.
The announcement was made a few weeks ago in the Federal Register by the DEA that the drug Syndros, a liquid form of synthetic THC, will be now classified as a schedule 2 controlled substance, which means it can be legally prescribed by doctors. Meanwhile, organic marijuana continues to be listed right alongside heroin among Schedule 1 controlled substances. This category is reserved for drugs that have “no currently accepted medical use” and “a high potential for abuse.” Other drugs that have proven time and time again to hold medicinal value seem to be stuck in this category as well, although some things are changing. Continue reading Synthetic Marijuana Approved By DEA For Medicine While The Real Thing Remains Illegal